School Of Medicine Basic Sciences
-
Study explores how bacteria become drug resistant
Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Read MoreJan 6, 2022
-
Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023
Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read MoreDec 21, 2021
-
A potential new approach for the treatment of schizophrenia
Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read MoreDec 8, 2021
-
Calipari named Dean’s Faculty Fellow
Erin Calipari, assistant professor of pharmacology and a member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. Read MoreNov 30, 2021
-
Watch: Lab-to-Table Conversations: “The Science of Beer” featuring biochemistry faculty and beer science alumni
Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read MoreNov 30, 2021
-
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Read MoreNov 22, 2021
-
Learn about the science of longevity with Vanderbilt experts in virtual event
The School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation will bring together research experts on Tuesday, Nov. 30, for a virtual discussion about our current understanding of the biology of longevity. Read MoreNov 15, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read MoreNov 15, 2021
-
Research Snapshot: New target identified for rapid antidepressant drugs
Vanderbilt researchers push research on ketamine’s role as a rapid antidepressant another step forward. This work opens avenues for new therapeutics for half of people for whom today’s antidepressants don’t work. Read MoreNov 10, 2021
-
Research Snapshot: Discovery shows how synapses are built and function in the nervous system
Discovering a signaling pathway’s influence on brain development in a nematode sheds light on human nervous systems. Est. reading time: 2 mins. Read MoreNov 8, 2021
-
Search committee announced to find next dean of School of Medicine Basic Sciences
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver has appointed a committee to conduct a national search for the next dean of the School of Medicine Basic Sciences. John Geer, Ginny and Conner Searcy Dean of the College of Arts and Science, will serve as chair. Read MoreNov 8, 2021
-
Uncovering how injury to the pancreas impacts cancer formation
Research from scientists at the School of Medicine Basic Sciences and the Salk Institute for Biological Studies shows that cells in the pancreas form new cell types to mitigate injury but are then susceptible to cancerous mutations. Read MoreOct 29, 2021
-
Research Snapshot: Professor discovers signaling pathway that lets ketamine act as a rapid antidepressant
Lisa Monteggia and her lab have identified how specific neurons in the hippocampus work to produce ketamine’s antidepressant action. Est. reading time: 2 mins. Read MoreOct 27, 2021
-
Global Vanderbilt: Carlos Lopez: “It’s beyond you’re welcome here, this is the place where you belong.”
Carlos Lopez, associate professor of biochemistry and biomedical informatics, describes how international faculty belong at Vanderbilt. Read MoreOct 21, 2021
-
Marnett stepping down as dean of Vanderbilt School of Medicine Basic Sciences
Lawrence J. Marnett, who has served as dean of Vanderbilt University’s School of Medicine Basic Sciences since its creation in 2016 and has led its dramatic ascension as one of the nation’s top biomedical research and doctoral programs, will step down as dean effective June 30, 2022. Read MoreOct 11, 2021
-
Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials
Appello Pharmaceuticals Inc. begins trial of a drug candidate that improves relief from symptoms of Parkinson’s disease without debilitating side effects. Read MoreOct 6, 2021
-
Three Vanderbilt scientists awarded NIH grants for high-risk, high-reward research
Vanderbilt scientists Katherine Aboud, PhD’19, Breann Brown and Will Wan, PhD’14, have received 2021 National Institutes of Health Director’s Awards for their unconventional, bold approaches to research that advances knowledge and enhances health. Read MoreOct 5, 2021
-
Research Snapshot: Sugar compounds in breast milk relieve uncomfortable side effects caused by chemotherapy
Steven Townsend, associate professor of chemistry, and Fang Yan, research professor of pediatrics and cell and development biology, have discovered how a sugar in human breast milk mitigates damage to the small intestines caused by chemotherapy-induced mucositis. Read MoreOct 4, 2021
-
Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects
Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and paradigm-shifting research. Read MoreSep 28, 2021
-
Watch Now: Jason Isbell on addiction and sobriety with Vanderbilt Center for Addiction Research
Four-time Grammy Award-winning musician Jason Isbell spoke about the impact of COVID-19 on addiction and sobriety and the intersection of sobriety, addiction and music in the School of Medicine Basic Sciences' Lab-to-Table Conversation on Tuesday, Oct. 12, at noon CT. Read MoreSep 28, 2021